CA Stock MarketDetailed Quotes

RX Biosyent Inc

Watchlist
  • 10.000
  • -0.040-0.40%
15min DelayMarket Closed Jul 12 16:00 ET
115.84MMarket Cap17.09P/E (TTM)

Biosyent Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
19.30%7.73M
13.12%31.59M
10.88%8.27M
30.63%8.87M
20.01%7.96M
-7.88%6.48M
-2.42%27.93M
3.37%7.46M
1.50%6.79M
-8.98%6.63M
Operating revenue
19.30%7.73M
13.12%31.59M
10.88%8.27M
30.63%8.87M
20.01%7.96M
-7.88%6.48M
-2.42%27.93M
3.37%7.46M
1.50%6.79M
-8.98%6.63M
Cost of revenue
38.49%1.59M
18.26%5.99M
23.72%1.57M
53.11%1.81M
25.23%1.47M
-20.65%1.15M
-15.27%5.07M
-9.21%1.27M
-17.56%1.18M
-26.19%1.17M
Gross profit
15.17%6.14M
11.99%25.6M
8.25%6.7M
25.90%7.06M
18.90%6.5M
-4.58%5.33M
0.97%22.86M
6.39%6.19M
6.70%5.61M
-4.19%5.46M
Operating expense
4.40%4.05M
13.24%18.06M
8.16%5.19M
13.01%4.29M
20.01%4.69M
12.91%3.88M
10.85%15.95M
40.79%4.8M
19.92%3.8M
-8.49%3.91M
Selling and administrative expenses
4.04%3.85M
13.36%17.27M
9.56%4.93M
13.40%4.16M
19.01%4.48M
12.07%3.7M
11.53%15.23M
40.41%4.5M
23.61%3.66M
-8.85%3.76M
-Selling and marketing expense
-28.09%1.07M
17.77%7.56M
20.88%2.6M
5.09%1.64M
41.22%1.83M
5.49%1.49M
6.35%6.42M
79.23%2.15M
31.85%1.56M
-37.71%1.3M
-General and administrative expense
25.68%2.78M
10.15%9.7M
-0.78%2.34M
19.56%2.51M
7.31%2.64M
16.99%2.21M
15.64%8.81M
17.22%2.35M
18.13%2.1M
20.61%2.46M
Research and development costs
134.20%88.21K
-31.20%83.27K
-14.87%41.54K
29.03%20.13K
--0
120.91%37.67K
-24.68%121.03K
9.64%48.8K
-81.94%15.6K
298.74%39.58K
Depreciation amortization depletion
4.14%114.99K
0.96%455.34K
-21.89%121.35K
14.79%111.94K
13.65%111.63K
10.54%110.42K
-1.34%451K
41.38%155.37K
-6.50%97.52K
-19.93%98.22K
-Depreciation and amortization
4.14%114.99K
0.96%455.34K
-21.89%121.35K
14.79%111.94K
13.65%111.63K
10.54%110.42K
-1.34%451K
41.38%155.37K
-6.50%97.52K
-19.93%98.22K
Provision for doubtful accounts
--0
180.81%140.32K
-23.86%38.05K
--0
--68.45K
--33.82K
--49.97K
--49.97K
--0
--0
Other operating expenses
----
20.99%117.93K
33.40%57.32K
-68.15%7.17K
205.79%37.38K
----
-15.87%97.47K
-10.40%42.97K
65.87%22.51K
-19.08%12.22K
Operating profit
43.96%2.09M
9.08%7.53M
8.56%1.51M
52.95%2.77M
16.09%1.8M
-32.52%1.45M
-16.26%6.91M
-42.24%1.39M
-13.36%1.81M
8.67%1.55M
Net non-operating interest income (expenses)
64.57%317.23K
136.87%1.06M
36.09%325.79K
114.81%274.52K
358.81%269.65K
749.15%192.76K
766.11%448.65K
1,284.85%239.39K
1,154.63%127.8K
521.00%58.77K
Non-operating interest income
58.14%332.82K
115.13%1.13M
32.61%342.18K
98.30%291.49K
266.65%286.99K
395.29%210.47K
283.66%525.8K
578.53%258.04K
367.62%146.99K
152.75%78.27K
Non-operating interest expense
-11.95%15.59K
-11.32%68.41K
-12.11%16.39K
-11.62%16.97K
-11.07%17.34K
-10.53%17.71K
-9.51%77.14K
-10.08%18.65K
-9.66%19.2K
-9.31%19.5K
Other net income (expenses)
96.68%-1.53K
-183.97%-63.11K
-15.44%16.56K
-52.28%20.04K
-240.33%-53.63K
-87.13%-46.08K
-4.85%75.16K
-83.33%19.58K
-58.41%41.99K
164.59%38.22K
Gain on sale of security
96.68%-1.53K
-183.97%-63.11K
-15.44%16.56K
-52.28%20.04K
-240.33%-53.63K
-87.13%-46.08K
263.35%75.16K
358.72%19.58K
-58.41%41.99K
164.59%38.22K
Income before tax
50.50%2.41M
14.85%8.53M
12.27%1.85M
54.71%3.06M
22.36%2.02M
-25.64%1.6M
-11.31%7.43M
-35.13%1.65M
-10.02%1.98M
19.63%1.65M
Income tax
50.50%637.7K
5.14%2.07M
-10.74%403.95K
35.16%711.3K
24.00%534.76K
-24.64%423.73K
-5.94%1.97M
-32.33%452.53K
10.03%526.25K
19.63%431.25K
Earnings from equity interest net of tax
Net income
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
19.63%1.22M
Net income continuous operations
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
19.63%1.22M
Noncontrolling interests
Net income attributable to the company
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
19.63%1.22M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
19.63%1.22M
Diluted earnings per share
56.70%0.152
21.85%0.541
24.00%0.124
67.23%0.199
25.51%0.123
-23.62%0.097
-10.30%0.444
-32.89%0.1
-12.50%0.119
22.50%0.098
Basic earnings per share
56.84%0.149
22.07%0.531
24.74%0.121
68.10%0.195
26.04%0.121
-24.00%0.095
-10.86%0.435
-34.01%0.097
-13.43%0.116
21.52%0.096
Dividend per share
12.50%0.045
300.00%0.16
0.00%0.04
0.04
0.04
0.04
0.04
0.04
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 19.30%7.73M13.12%31.59M10.88%8.27M30.63%8.87M20.01%7.96M-7.88%6.48M-2.42%27.93M3.37%7.46M1.50%6.79M-8.98%6.63M
Operating revenue 19.30%7.73M13.12%31.59M10.88%8.27M30.63%8.87M20.01%7.96M-7.88%6.48M-2.42%27.93M3.37%7.46M1.50%6.79M-8.98%6.63M
Cost of revenue 38.49%1.59M18.26%5.99M23.72%1.57M53.11%1.81M25.23%1.47M-20.65%1.15M-15.27%5.07M-9.21%1.27M-17.56%1.18M-26.19%1.17M
Gross profit 15.17%6.14M11.99%25.6M8.25%6.7M25.90%7.06M18.90%6.5M-4.58%5.33M0.97%22.86M6.39%6.19M6.70%5.61M-4.19%5.46M
Operating expense 4.40%4.05M13.24%18.06M8.16%5.19M13.01%4.29M20.01%4.69M12.91%3.88M10.85%15.95M40.79%4.8M19.92%3.8M-8.49%3.91M
Selling and administrative expenses 4.04%3.85M13.36%17.27M9.56%4.93M13.40%4.16M19.01%4.48M12.07%3.7M11.53%15.23M40.41%4.5M23.61%3.66M-8.85%3.76M
-Selling and marketing expense -28.09%1.07M17.77%7.56M20.88%2.6M5.09%1.64M41.22%1.83M5.49%1.49M6.35%6.42M79.23%2.15M31.85%1.56M-37.71%1.3M
-General and administrative expense 25.68%2.78M10.15%9.7M-0.78%2.34M19.56%2.51M7.31%2.64M16.99%2.21M15.64%8.81M17.22%2.35M18.13%2.1M20.61%2.46M
Research and development costs 134.20%88.21K-31.20%83.27K-14.87%41.54K29.03%20.13K--0120.91%37.67K-24.68%121.03K9.64%48.8K-81.94%15.6K298.74%39.58K
Depreciation amortization depletion 4.14%114.99K0.96%455.34K-21.89%121.35K14.79%111.94K13.65%111.63K10.54%110.42K-1.34%451K41.38%155.37K-6.50%97.52K-19.93%98.22K
-Depreciation and amortization 4.14%114.99K0.96%455.34K-21.89%121.35K14.79%111.94K13.65%111.63K10.54%110.42K-1.34%451K41.38%155.37K-6.50%97.52K-19.93%98.22K
Provision for doubtful accounts --0180.81%140.32K-23.86%38.05K--0--68.45K--33.82K--49.97K--49.97K--0--0
Other operating expenses ----20.99%117.93K33.40%57.32K-68.15%7.17K205.79%37.38K-----15.87%97.47K-10.40%42.97K65.87%22.51K-19.08%12.22K
Operating profit 43.96%2.09M9.08%7.53M8.56%1.51M52.95%2.77M16.09%1.8M-32.52%1.45M-16.26%6.91M-42.24%1.39M-13.36%1.81M8.67%1.55M
Net non-operating interest income (expenses) 64.57%317.23K136.87%1.06M36.09%325.79K114.81%274.52K358.81%269.65K749.15%192.76K766.11%448.65K1,284.85%239.39K1,154.63%127.8K521.00%58.77K
Non-operating interest income 58.14%332.82K115.13%1.13M32.61%342.18K98.30%291.49K266.65%286.99K395.29%210.47K283.66%525.8K578.53%258.04K367.62%146.99K152.75%78.27K
Non-operating interest expense -11.95%15.59K-11.32%68.41K-12.11%16.39K-11.62%16.97K-11.07%17.34K-10.53%17.71K-9.51%77.14K-10.08%18.65K-9.66%19.2K-9.31%19.5K
Other net income (expenses) 96.68%-1.53K-183.97%-63.11K-15.44%16.56K-52.28%20.04K-240.33%-53.63K-87.13%-46.08K-4.85%75.16K-83.33%19.58K-58.41%41.99K164.59%38.22K
Gain on sale of security 96.68%-1.53K-183.97%-63.11K-15.44%16.56K-52.28%20.04K-240.33%-53.63K-87.13%-46.08K263.35%75.16K358.72%19.58K-58.41%41.99K164.59%38.22K
Income before tax 50.50%2.41M14.85%8.53M12.27%1.85M54.71%3.06M22.36%2.02M-25.64%1.6M-11.31%7.43M-35.13%1.65M-10.02%1.98M19.63%1.65M
Income tax 50.50%637.7K5.14%2.07M-10.74%403.95K35.16%711.3K24.00%534.76K-24.64%423.73K-5.94%1.97M-32.33%452.53K10.03%526.25K19.63%431.25K
Earnings from equity interest net of tax
Net income 50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M19.63%1.22M
Net income continuous operations 50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M19.63%1.22M
Noncontrolling interests
Net income attributable to the company 50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M19.63%1.22M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M19.63%1.22M
Diluted earnings per share 56.70%0.15221.85%0.54124.00%0.12467.23%0.19925.51%0.123-23.62%0.097-10.30%0.444-32.89%0.1-12.50%0.11922.50%0.098
Basic earnings per share 56.84%0.14922.07%0.53124.74%0.12168.10%0.19526.04%0.121-24.00%0.095-10.86%0.435-34.01%0.097-13.43%0.11621.52%0.096
Dividend per share 12.50%0.045300.00%0.160.00%0.040.040.040.040.040.04
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg